期刊文献+

半乳凝素3在不稳定心绞痛诊疗中的临床价值研究 被引量:2

The value of Galectin-3 in the diagnosis of unstable angina
原文传递
导出
摘要 目的 :分析半乳凝素3(Gal-3)在不稳定心绞痛诊疗中的临床价值。方法 :分析2012年1月~2014年1月在我院接受诊疗的冠心病患者的临床资料。依据患者冠心病的疾病状态分为2组,观察组(不稳定性心绞痛)及对照组(稳定性心绞痛)。结果 :本研究共纳入患者96例,其中观察组46例,对照组50例。观察组患者血清CRP显著高于对照组;观察组患者血清Gal-3水平显著高于对照组。Pearson相关性检验显示,观察组患者血清CRP与Gal-3呈现显著正相关关系,具有统计学意义。ROC曲线分析显示,当Gal-3取值为5.87ng/m L时预测敏感性为91.30%,特异性为92.00%,优于CRP。结论 :半乳凝素3可用以辅助诊疗不稳定心绞痛。 Objective Our study was aimed toanalyze the value of Galectin-3(Gal-3) in the diagnosis of unstable angina. Methods Clinical data of patients with coronary heart disease received treatment at ourhospitalfrom 2012 to 2014 was analyzed. Patients were divided into two groups by the disease activity state, Group A: Unstable angina; Group B:stable angina. ResultsA total of 96 patients were analyzed, Group A46 cases, Group B 50 cases. Group A patients had higher levels of CRP and Gal-3than these of Group B patients, the difference was statistically significant(P<0.05). Correlation analysis showed that, for Group A patients, the levels of CRP had significant positive correlation with Gal-3(t=0.813,P<0.001). ROC analysis showed that the Gal-3 cut-off point value of 5.87ng/ml, as used for the diagnosis of unstable angina, provided a sensitivity of 91.30%, a specificity of 92.00%, better than these of CRP. Conclusion Gal-3 can be used as a diagnosis index of unstable angina for patients with coronary heart disease.
出处 《湖南师范大学学报(医学版)》 2015年第5期22-24,25,共4页 Journal of Hunan Normal University(Medical Sciences)
关键词 冠心病 半乳凝素3 炎症因子 诊断 Coronary heart disease Galectin-3 Inflammatory factor Diagnosis
  • 相关文献

参考文献1

二级参考文献35

  • 1Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Girt MA, et al. Galectins: a family of animal beta-galactoside?binding lectins. Cell 1994, 76: 597-598.
  • 2Barondes SH, Cooper DN, Girt MA, Leffler H. Galectins. Structure and function of a large family of animal lectins. J Bioi Chem 1994, 269: 20807-20810.
  • 3Dumic J, Dabelic S, Flogel M. Galectin-3: an open-ended story. Biochim Biophys Acta 2006, 1760: 616-635.
  • 4Seetharaman J, Kanigsberg A, Slaaby R, Leffler H, Barondes SH, Rini JM. X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution.J Biol Chem 1998,273: 13047-13052.
  • 5Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta 2002, 1572: 263-273.
  • 6Cooper DN. Galectinomics: finding themes in complexity. Biochim Biophys Acta 2002, 1572: 209-231.
  • 7Henderson NC, Sethi T. The regulation of inflammation by galectin-S, lmmunol Rev 2009, 230: 160-171.
  • 8Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JP, Schroen B, Andre S, et al. Galecrin-J marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 2004,110: 3121-3128.
  • 9Yan YP, Lang BT, Vemuganti R, Dempsey RJ. Galectin-3 mediates post?ischemic tissue remodeling. Brain Res 2009, 1288: 116-124.
  • 10Lin CI, Whang EE, Donner DB, Jiang X, Price BD, Carothers AM, Delaine T, et al. Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer. Mol Cancer Res 2009, 7: 1655-1662.

共引文献3

同被引文献13

引证文献2

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部